henhaobio
Sign in

bioRxivNeurosciencePreprint

Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response

Gabriele FlorisiD, Sarah J. JeffersoniD, Jocelyne A. Rondeau, Abigail L. YuiD, Frank S. MennitiiD, Alex C. KwaniD, João Paulo De AquinoiD, John H. Krystal, Christopher PittengeriD, Alfred P. KayeiD

PDFDOI

Abstract

Psilocybin has antidepressant effects, but its 5-HT2AR-mediated perceptual effects limit tolerability. We combined psilocybin with a phosphodiesterase-9 inhibitor (PDE9i) and observed suppression of head-twitch response, but maintenance of antidepressant-like behavior. Proteomics showed that PDE9i-psilocybin reduced 5-HT2AR-mediated pathways while enhancing synaptogenesis. These results suggest that PDE9i-psilocybin represents a promising therapeutic strategy.

Citations
0

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISShao '24Raithatha '23Shahar '22Pacheco '23Claydon '26Vella '25
73% semantic matchNeuroscience
Ling-Xiao Shao, Clara Liao, Pasha A. Davoudian+11 more·bioRxiv·Nov 2, 2024· 1 citations